(Q37138955)
Statements
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors (English)
Con Panousis
Kirsten M Edwards
Veronika Rayzman
Matthew P Hardy
Hal Braley
Gail M Gauvreau
Roma Sehmi
Laura McMillan
Mara Dottore
Barbara J McClure
Gino Vairo
Andrew D Nash
Nicholas J Wilson
Michael J Wilson
Catherine M Owczarek
14 December 2015
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference